- 询价
- abinScience
- China
- VK500082
- 2026年03月03日
企业认证
相关产品推荐更多 >
Recombinant Human METTL21C Protein (N-His Tag), 重组人METTL21C蛋白 (N端His标签)
￥1868
Recombinant Human RBM47 Protein (N-His Tag), 重组人RBM47蛋白 (N端His标签)
询价
Recombinant McHV-1 gI Protein (C-Fc Tag), 重组McHV-1gI蛋白 (C端Fc标签)
询价
Recombinant Pig CD163 Protein, N-His, 重组猪CD163蛋白 (N端His标签)
￥211Recombinant Human NPR1 Protein (C-Strep Tag), 重组人NPR1蛋白 (C端Strep标签)
￥1868
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
- 保质期：
1 year
- 英文名：
Recombinant FMDV VP1 Protein, N-His
- 供应商：
abinScience
- 规格：
50ug/100ug/1mg
| Product name | Recombinant FMDV VP1 Protein, N-His |
|---|---|
| Catalog No. | VK500082 |
| Form | Lyophilized |
| Storage buffer | Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol. |
| Purity | >90% as determined by SDS-PAGE. |
| Applications | ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress |
| Target | / |
| Expression system | E. coli |
| Accession | P03307 |
| Protein length | Thr726-Gln935 |
| Alternative Names | Genome polyprotein, Leader protease, Lpro, EC:3.4.22.46, Capsid protein VP0, VP4-VP2, Capsid protein VP4, P1A, Virion protein 4, Capsid protein VP2, P1B, Virion protein 2, Capsid protein VP3, P1C, Virion protein 3, Capsid protein VP1, P1D, Virion protein 1, Protein 2A, P2A, P52, Protein 2B, P2B, Protein 2C, P2C, EC:3.6.1.15, Protein 3A, P3A, Protein 3B-1, P3B-1, Genome-linked protein VPg1, Protein 3B-2, P3B-2, Genome-linked protein VPg2, Protein 3B-3, P3B-3, Genome-linked protein VPg3, Protease 3C, EC:3.4.22.28, Picornain 3C, P3C, Protease P20B, RNA-directed RNA polymerase 3D-POL, P3D-POL, EC:2.7.7.48, P56A |
| Predicted molecular weight | 25.32 kDa |
| Applications.1 | ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress |
| Protein length.1 | Thr726-Gln935 |
| Species | Foot-and-mouth disease virus (isolate -/Germany/A5Westerwald/1951 serotype A) (FMDV) |
abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.
Technology and Innovation
Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003, abinScience has inherited advanced technologies and high-quality standards. In particular, the XtenCHO™ system developed by ProteoGenix, which has two modes of transient expression and stable expression, has been widely recognized as a core technology to improve the efficiency of protein production, providing a solid foundation for ab...
Product categories and application fields.
Main products.
10000+ high-activity proteins.
15000+ antibody series products:
Classic monoclonal antibody.
Monoclonal antibody
Internal control antibody, labeled antibody.
High-quality phosphorylation antibodies.
Highly specific nanobodies and small molecule antibodies.
Functional antibodies in vivo.
Low-background flow cytometry antibodies.
DNA/RNA antibodies and PEG antibodies.
1000+ reagent kit series products.
Large-scale packaging customization services: We offer personalized antibody design, protein production, molecular optimization, and experimental development services.
Application field
Infectious disease research: including viruses, superbugs, parasites, etc.
Neuroscience research: Supporting research on neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Immunology research: Covers the research needs of immune activation, inhibition, and allergies and abnormal reactions.
Oncology research: Supporting the development of tumor biology and anti-tumor drugs.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验• Impact of VP2 structure on antigenicity: comparison of BTV1 and the highly virulent BTV8 serotype., PMID:39320096
• Identification of Potential Novel B-Cell Epitopes of Capsid Protein VP2 in Senecavirus A., PMID:37428080
• Conserved Rotavirus NSP5 and VP2 Domains Interact and Affect Viroplasm., PMID:31915278
• Neddylation of Enterovirus 71 VP2 Protein Reduces Its Stability and Restricts Viral Replication., PMID:35510863
• Sialic Acid Binding Sites in VP2 of Bluetongue Virus and Their Use during Virus Entry., PMID:34669428
• A potential dual protection vaccine: Recombinant feline herpesvirus-1 expressing feline parvovirus VP2 antigen., PMID:38185071
• Production of infectious reporter murine norovirus by VP2 trans-complementation., PMID:38226813
• Interaction between the VP2 protein of deformed wing virus and host snapin protein and its effect on viral replication., PMID:36846748
• Preparation and immunogenicity studies of NvIBDV VP2-ferritin nanoparticles., PMID:40764574
信息 1、Recombinant Gene Expression : Reviews and Protocols Editor(s): Paulina Balbás1, Argelia Lorence2 Affiliation(s): (1),Centro de Investigación en Biotecnología,CuernavacaMéxico (2)Virginia Polytechnic Institute,State University,BlacksburgVA
粒子,在RGD 附近区段发生突变的cRNA 则能产生感染性病毒。为了进一步证明这些没有感染性的病毒只是由于在细胞吸附位点上有缺陷, 他们又将在RGD 序列内部发生点突变的cRNA 与表达有野生型P1 蛋白的cRNA 共转染细胞,结果产生有感染性的病毒粒子,因而也证明了FMDV RGD 序列在病毒吸附过程中具有重组作用。 5. 2 构建嵌合病毒研究基因变异与毒力之间的关系 Sa2carvalho D 等[13 ]构建了一种嵌合病毒,即把两个不同血清型的O1 株编码核衣壳蛋白的cDNA序列插入A12
如下：几丁质结合蛋白域―intein1―MCS―Intein2―几丁质结合蛋白。这个巧妙的设计有3重便利：N-端，C-端或者N-端和C-端同时融合短的内含肽序列。想做N端融合，你可以将目的基因替换MCS―Intein2―几丁质结合蛋白，如果想做C端融合表达，就可以将目的基因替换MCS前面的几丁质结合蛋白域―intein1―MCS，不用分2个载体；而且做过克隆的人会很有体会：很多时候双酶切载体，由于2个酶切位点都多克隆位点上，没有小片断切下来，所以是否成功双酶切就不好判断，如果用Twin载体就会切下一个片断
技术资料暂无技术资料 索取技术资料
